Alnylam Pharmaceuticals I... (ALNY)
NASDAQ: ALNY
· Real-Time Price · USD
456.35
-4.64 (-1.01%)
At close: Oct 03, 2025, 3:59 PM
455.47
-0.19%
After-hours: Oct 03, 2025, 07:00 PM EDT
Alnylam Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -319.09M | -269.7M | -278.16M | -332.26M | -72.94M | -332.08M | -440.24M | -509.87M | -1.06B | -1.06B | -1.13B | -1.18B | -980.72M | -892.87M | -852.82M | -837.9M | -886.68M | -876.35M |
Depreciation & Amortization | 56.5M | 57.56M | 56.67M | 90.7M | 65.53M | 73.98M | 86.54M | 97.94M | 95.06M | 102.17M | 85.55M | 82.12M | 84.69M | 76.29M | 89.69M | 89.12M | 84.67M | 80.29M |
Stock-Based Compensation | 305.84M | 283.45M | 272.08M | 222.43M | 240.57M | 227.08M | 221.68M | 222.45M | 286.63M | 241.3M | 230.65M | 232.46M | 137.71M | 139.32M | 165.72M | 155.41M | 159.31M | 160.99M |
Other Working Capital | -41.54M | -175.44M | -232.22M | -249.17M | -217.49M | -94.46M | -509K | -74.15M | -102.92M | -117.65M | -147.59M | -87.95M | -106.03M | -98.06M | -95.72M | -67.18M | -38.45M | -2.13M |
Other Non-Cash Items | 132.29M | 183.78M | 154.72M | 261.41M | 290.77M | 229.11M | 210.44M | 133.08M | 210.88M | 246.62M | 309.24M | 339.52M | 235.35M | 205.63M | 174.24M | 160.57M | 153.51M | 154.06M |
Deferred Income Tax | 19.37M | 9.64M | 454K | -52.65M | -13.39M | 15.43M | 14.97M | 68.07M | 28.82M | n/a | n/a | 5.58M | -13.11M | -8.68M | -55.7M | -48.69M | -26.98M | -76.95M |
Change in Working Capital | -210.45M | -309.83M | -214.08M | -133.08M | -138.28M | -24.4M | 10.76M | -9.71M | -30.58M | -61.73M | -35.55M | -36.99M | -42.11M | -96.92M | -162.82M | -133.2M | -74.81M | -46.49M |
Operating Cash Flow | -15.54M | -45.11M | -8.31M | 56.55M | 372.26M | 189.12M | 104.16M | 1.97M | -472.72M | -536.56M | -541.27M | -559.44M | -578.19M | -577.23M | -641.69M | -614.7M | -590.99M | -604.46M |
Capital Expenditures | -36.55M | -30.27M | -34.28M | -40.49M | -53.39M | -61.29M | -62.21M | -68.54M | -67.95M | -68.09M | -72.06M | -72.31M | -81.86M | -77.05M | -76.37M | -76.15M | -62.51M | -67.92M |
Cash Acquisitions | n/a | n/a | n/a | 225.35M | 214.58M | 207.38M | 158.15M | -67.2M | -56.43M | -49.23M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.86B | -1.7B | -1.71B | -1.81B | -1.79B | -1.85B | -1.82B | -1.96B | -1.69B | -1.78B | -1.98B | -1.94B | -2.24B | -1.94B | -1.66B | -1.53B | -1.4B | -1.98B |
Sales Maturities Of Investments | 1.72B | 1.75B | 1.63B | 1.55B | 1.56B | 1.59B | 1.55B | 1.79B | 1.86B | 2.1B | 2.23B | 1.92B | 1.82B | 1.53B | 1.46B | 1.67B | 1.61B | 1.59B |
Other Investing Acitivies | 57.96M | 48.71M | -117K | -225.35M | -219.02M | -211.81M | -162.59M | 63.14M | 51.81M | 36.11M | -13.19M | -13.58M | -8.58M | -241K | -4.36M | -25.36M | -25.36M | -25.5M |
Investing Cash Flow | -110.77M | 64.55M | -116.84M | -304.59M | -285.1M | -327.75M | -336.35M | -235.6M | 89.05M | 240.56M | 169.35M | -104.14M | -506.3M | -492.07M | -273.3M | 42.22M | 120.4M | -477.85M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -777K | 135.39M | 135.39M | 135.39M | 386.17M | 743.75M | 987.5M | 987.5M | 932.23M | 438.48M | 686.6M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -43.31M | -17.12M | -8.79M | 4.82M | 18.44M | 23.72M | 24.67M | 23.83M | 23.33M | 27.17M | 31M | 20.75M | 20.62M | 16.98M | 13.35M | 20.3M | 16.8M | 110.24M |
Financial Cash Flow | 231.59M | 309.33M | 294.16M | 302.39M | 232.77M | 154.67M | 172.13M | 196.34M | 460.23M | 437.17M | 425.75M | 654.61M | 931.42M | 1.23B | 1.25B | 1.17B | 633.09M | 992.29M |
Net Cash Flow | 144.67M | 337.67M | 153.26M | 66.77M | 310.7M | 9.65M | -53.68M | -40.18M | 82.24M | 138.15M | 46.4M | -21.07M | -170.33M | 154.25M | 323.11M | 597.3M | 164.78M | -88.39M |
Free Cash Flow | -52.09M | -75.39M | -42.59M | 16.06M | 318.87M | 127.82M | 41.95M | -66.56M | -540.68M | -604.65M | -613.33M | -631.75M | -660.05M | -654.28M | -718.07M | -690.85M | -653.5M | -672.38M |